Nevro Corp. NVRO reported a loss per share of 41 cents in the third quarter of 2024, narrower than the year-ago quarter’s ...

Nevro Corp. (NYSE:NVRO) just released its latest quarterly results and things are looking bullish. Results overall were solid, with revenues arriving 4.2% better than analyst forecasts at US$97m.

Truist Financial analyst Richard Newitter maintained a Hold rating on Nevro Corp (NVRO – Research Report) today and set a price target of $7.00. The company’s shares closed yesterday at $5.06.

Q3 2024 Earnings Call Transcript November 11, 2024 Nevro Corp. beats earnings expectations. Reported EPS is $-0.51, expectations were $-0.81. Operator: Good afternoon. My name is Krista, and I will be ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Quanterix (QTRX – Research Report), Nevro ...

Nevro (NYSE:NVRO – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Monday, ...

Nevro (NYSE:NVRO) announced today that it received CE mark in Europe for its HFX iQ spinal cord stimulation (SCS) system.

Baird reaffirms Nevro with a Neutral and raises the price target from $5 to $6. RBC Capital reiterates Nevro with a Sector ...

Check the time stamp on this data. Updated AI-Generated Signals for Nevro Corp. (NVRO) available here: NVRO.

Nevro Corp (NYSE:NVRO) is set to release its Q3 2024 earnings on Nov 11, 2024. The consensus estimate for Q3 2024 revenue is ...

The Redwood City, California-based company said it had a loss of 41 cents per share. Losses, adjusted for non-recurring gains, came to 51 cents per share. The results exceeded Wall Street expectations ...

NVRO) reported Q2 FY23 revenue of $108.8 million, up 4% Y/Y, missing the management guidance of $110 million-$112 million and ...